Harpum Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries

1. Auflage 2011
ISBN: 978-0-470-88896-4
Verlag: John Wiley & Sons
Format: EPUB
Kopierschutz: 0 - No protection

E-Book, Englisch, 352 Seiten, E-Book

This book describes the way that pharmaceutical projects and programs are currently managed, and offers views from many highly experienced practitioners from within the industry on future directions for drug program management. The book integrates portfolio, program, and project management processes as fundamental for effective and efficient drug product development. Contributing expert authors provide their view of how the projectization approach can be taken forward by the drug industry over the coming years.

Autoren/Hrsg.

Harpum, Pete

Inhaltsverzeichnis

Preface.
Acknowledgments.
About the Authors.
Part One The Life Science Industry Context for Portfolio,Program, and Project Management.
1 A Review of Project Management in Life Science IndustrySectors (Thomas R. Dunson).
2 The Impact of Organizational Size on Drug Project Management(Eric Morfin).
3 Drug Development in Biotechnology and How We Can Do It Better(Susan Linna).
Part Two The Portfolio, Program, and Project ManagementApproaches and Processes.
4 An Overview of the Organization and Processes of Portfolio,Program, and Project Management (Pete Harpum).
5 Portfolio Management in the Pharmaceutical Industry: BalancingCorporate Need with the Reality of Delivering Products to theMarket (John Bennett).
6 Program Management in Drug Development (PaulineStewart-Long).
7 Project Control (Martin Powell).
8 Managing Uncertainty in Drug Projects (Pete Harpum andThomas R. Dunson).
9 Managing Drug Safety Risk (Thomas R. Dunson and EricMorfin).
10 Developing Program Strategy (Pete Harpum).
11 Developing Products with "Added Value" (Trevor J.Brown and Stephen Allport).
Part Three Integrating the Processes.
12 Integrated Business Processes to Support Cross-FunctionalDrug Development (Martin D. Hynes III).
13 Integrated Drug Development From Cradle to Grave and From Labto Market (Stephen Allport and Terry Cook-Davies).
14 The Development of P³M Capability in DrugDevelopment Organizations (John Arrowsmith, Patrick Grogan andBob Moore).
15 Implementing Portfolio, Program, and Project Management BestPractices in Drug Development Organizations (Pete Harpum, AshleyJamieson and Inge Fisher).
Bibliography.
Index.

Über Autor(innen)

Pete Harpum is a Director of Harpum Consulting and has been consulting on Portfolio, Program, and Project Management (P³M) for some ten years. He chairs and contributes to many conferences and symposiums on P³M. Mr. Harpum's other activities include postgraduate lecturing and research on P³M for three world-class universities, and supporting the Association for Project Management, Project Management Institute, and the Drug Information Association in various ways.